NEW YORK (GenomeWeb) – CombiMatrix today reported a 37 percent increase in second quarter revenues, driven by higher test volumes in its reproductive health and pediatric segments as well as improved test reimbursement across all segments.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.